series-b
Stage
1
Investors
About
Marea Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies for cardioendocrine diseases by leveraging advances in human genetics.
Explore Marea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.